Metropolis Healthcare cash flow

Latest FY26

Cash from operations: ₹351cr+33.5% on FY25
Capital spending: ₹51.2cr−25.4% on FY25
Free cash flow: ₹300cr+54.3% on FY25
Cash from financing: −₹115cr−₹86.6 cr in FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Changes in working capital
Adjustments to reconcile profit — non-cash items						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	—	134	109	94.5	89.2
	—	0.0	18.6	0.0	16.6
	—	0.0	−7.5	−0.2	−0.7
	—	8.1	7.0	1.4	0.3
	—	−5.1	2.4	−3.3	0.2
	—	6.2	3.1	−2.9	−6.0
	—	−0.6	0.0	2.9	0.0
	—	−0.0	0.0	0.1	0.1
	—	0.0	1.9	5.9	6.5
	—	−49.0	−9.1	−12.4	15.8
	—	0.9	0.0	0.0	−1.1
	—	−1.8	−3.7	4.6	0.0
	—	3.2	−2.5	−6.2	−1.8
	—	−12.6	0.0	0.0	0.0
	—	−2.3	4.8	5.7	−5.3
	—	22.1	−0.5	−1.0	−3.2
	—	3.9	0.0	0.0	0.0
	—	1.1	−6.1	18.6	−3.6
	—	0.0	0.0	7.3	0.1
	—	25.8	2.3	15.0	−0.2
	—	4.2	0.0	0.0	0.0
Cash from operating activities
	276	259	191	175	188
	—	138	119	130	107
	—	397	310	305	294
	—	−2.4	−2.7	−3.3	−5.2
	—	−2.3	0.0	0.0	−10.1
	—	0.4	0.0	0.0	−0.6
	—	46.6	44.7	37.4	51.6
	—	351	263	264	247
Cash from investing activities
	—	43.5	43.4	63.8	52.6
	—	−7.7	25.2	0.0	0.0
	—	−0.3	2.0	0.0	0.1
	—	113	0.0	0.0	0.0
	—	0.0	−8.4	0.0	0.0
	—	411	0.0	0.0	0.0
	—	348	0.0	0.0	0.0
	—	0.0	0.4	0.0	0.0
	—	0.0	131	0.0	0.0
	—	1.7	5.1	2.2	6.5
	—	−12.4	0.0	−27.8	92.8
	—	−223	−201	−89.4	46.8
Cash from financing activities
	—	0.0	0.0	0.0	0.0
	—	−6.6	0.0	0.0	0.0
	—	0.0	0.8	79.1	179
	—	81.3	67.3	18.6	45.4
	—	—	—	59.2	0.0
	—	24.4	0.1	3.9	27.3
	—	20.7	18.5	20.5	41.0
	—	4.5	0.0	0.0	0.2
	—	−115	−86.6	−181	−292
	—	12.3	−24.9	−6.5	1.6
	—	3.0	1.0	0.3	1.3
	—	15.3	−24.0	−6.2	2.9
	—	—	39.5	62.6	68.8
Reference items
	422	401	303	283	288
	24.7%	24.4%	22.8%	23.4%	25.1%
	300	300	194	200	194
	—	280	208	117	—
	₹14.45	₹14.45	₹9.36	₹9.66	₹9.38
	38.34×	—	—	—	—
	—	1.83×	1.81×	2.06×	1.72×
	—	46.6	44.7	37.4	51.6
	—	24.4	0.1	3.9	27.3

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

METROPOLIS₹553.85

Metropolis Healthcare Ltd.

· Pharma & Health

₹ CrorePeersLALPATHLAB VIJAYA THYROCARE MARKSANS PARKHOSPS JLHL RUBICON HCGMcap ₹11,483 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation	89.2	94.5	108.7	133.7	—
+ Finance Costs	16.6	0.0	18.6	0.0	—
+ Fair Value (Gains) / Losses	-0.7	-0.2	-7.5	0.0	—
+ Share-based Payments	0.3	1.4	7.0	8.1	—
+ Unrealised FX (Gain) / Loss	0.2	-3.3	2.4	-5.1	—
+ Other Non-cash Items	-6.0	-2.9	3.1	6.2	—
+ Other — Cash Effects are Investing / Financing	0.0	2.9	0.0	-0.6	—
+ Other Reconciling Items	0.1	0.1	0.0	-0.0	—
Changes in Working Capital
+ Inventories	6.5	5.9	1.9	0.0	—
+ Trade Receivables — Current	15.8	-12.4	-9.1	-49.0	—
+ Other Financial Assets — Current	-1.1	0.0	0.0	0.9	—
+ Other Financial Assets — Non-current	0.0	4.6	-3.7	-1.8	—
+ Other Current Assets	-1.8	-6.2	-2.5	3.2	—
+ Other Non-current Assets	0.0	0.0	0.0	-12.6	—
+ Trade Payables — Current	-5.3	5.7	4.8	-2.3	—
+ Other Financial Liabilities — Current	-3.2	-1.0	-0.5	22.1	—
+ Other Financial Liabilities — Non-current	0.0	0.0	0.0	3.9	—
+ Other Current Liabilities	-3.6	18.6	-6.1	1.1	—
+ Other Non-current Liabilities	0.1	7.3	0.0	0.0	—
+ Provisions — Current	-0.2	15.0	2.3	25.8	—
+ Provisions — Non-current	0.0	0.0	0.0	4.2	—
Cash from Operating Activities
Profit Before Tax (per I/S)	187.5	174.7	190.9	259.2	275.7
+ Total Adjustments (incl. Working Capital)	106.8	130.0	119.4	137.8	—
Cash from Operations (pre-tax)	294.3	304.7	310.2	397.0	—
+ Interest Received — Operating	-5.2	-3.3	-2.7	-2.4	—
+ Interest Paid — Operating	-10.1	0.0	0.0	-2.3	—
+ Other Inflows / (Outflows) — Operating	-0.6	0.0	0.0	0.4	—
+ Income Taxes Paid	51.6	37.4	44.7	46.6	—
Cash from Operating Activities	247.1	264.1	262.7	350.7	—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)	52.6	63.8	43.4	43.5	—
+ Acq of Intangible Assets	0.0	0.0	25.2	-7.7	—
+ Disp of Fixed Assets	0.1	0.0	2.0	-0.3	—
+ Acq of Investment Property	0.0	0.0	0.0	113.4	—
+ Disp of Investment Property	0.0	0.0	-8.4	0.0	—
+ Acq of Other Long-term Assets	0.0	0.0	0.0	411.3	—
+ Disp of Other Long-term Assets	0.0	0.0	0.0	348.3	—
+ Purchase of Investments (Equity / Debt)	0.0	0.0	0.4	0.0	—
+ Acq of Subsidiaries / Businesses (net)	0.0	0.0	130.8	0.0	—
+ Interest Received — Investing	6.5	2.2	5.1	1.7	—
+ Other Inflows / (Outflows) — Investing	92.8	-27.8	0.0	-12.4	—
Cash from Investing Activities	46.8	-89.4	-201.1	-223.1	—
Cash from Financing Activities
+ Proceeds from Exercise of Stock Options	0.0	0.0	0.0	0.0	—
+ Buyback / Redemption of Own Shares	0.0	0.0	0.0	-6.6	—
+ Repayment of Borrowings	178.9	79.1	0.8	0.0	—
+ Payment of Lease Liabilities	45.4	18.6	67.3	81.3	—
+ Payment of Finance Lease Liabilities	0.0	59.2	—	—	—
+ Interest Paid	27.3	3.9	0.1	24.4	—
+ Dividends Paid	41.0	20.5	18.5	20.7	—
+ Other Inflows / (Outflows) — Financing	0.2	0.0	0.0	4.5	—
Cash from Financing Activities	-292.3	-181.2	-86.6	-115.3	—
Net Changes in Cash (pre-FX)	1.6	-6.5	-24.9	12.3	—
+ Effect of FX Rate Changes on Cash	1.3	0.3	1.0	3.0	—
Net Changes in Cash	2.9	-6.2	-24.0	15.3	—
Closing Cash	68.8	62.6	39.5	—	—
Reference Items
EBITDA	288.3	282.6	303.0	400.8	422.3
EBITDA Margin %	25.11	23.40	22.76	24.36	24.69
Free Cash Flow (CFO − Capex)	194.5	200.3	194.1	299.5	299.5
Free Cash Flow to Equity	—	117.4	208.2	279.6	—
Free Cash Flow per Basic Share	9.38	9.66	9.36	14.45	14.45
Price to Free Cash Flow	—	—	—	—	38.34
Cash Flow to Net Income	1.72	2.06	1.81	1.83	—
Cash Paid for Taxes	51.6	37.4	44.7	46.6	—
Cash Paid for Interest	27.3	3.9	0.1	24.4	—

As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.